Selvadurai Hiran C, McKay Karen O, Blimkie Cameron J, Cooper Peter J, Mellis Craig M, Van Asperen Peter P
Children's Chest Research Centre, Department of Respiratory Medicine, Children's Hospital Institute of Sports Medicine, The Children's Hospital at Westmead, New South Wales, Australia.
Am J Respir Crit Care Med. 2002 Mar 15;165(6):762-5. doi: 10.1164/ajrccm.165.6.2104036.
The relationship between fitness and genotype in children with cystic fibrosis (CF) and at least one copy of the DeltaF508 mutation was examined. Genotype was classified according to the second CF mutation. Fitness was measured by peak aerobic capacity (using a modified Bruce protocol during treadmill exercise) and anaerobic power (using the Wingate test on a cycle ergometer). The class of cystic fibrosis transmembrane regulator proteins (CFTR) mutation was statistically related with aerobic capacity, peak anaerobic power, body mass index, lung function (forced expiratory volume in one second), and disease severity as measured by the Shwachman score. Patients with mutations causing defective CFTR production (Class I) or processing (Class II) had a significantly lower peak aerobic capacity (28.6 +/- 4.2 ml/kg/min and 31.7 +/- 5.4 ml/kg/min, respectively) than those with a mutation conferring defective regulation of CFTR (Class III) (43.9 +/- 6.4 ml/kg/min). The peak anaerobic power in subjects with mutations inducing decreased CFTR conduction (Class IV) or CFTR mRNA (Class V), were significantly higher (11.4 +/- 1.7 and 11.6 +/- 1.5 watts/kg, respectively) than children with Class I (9.7 +/- 1.4 watts/kg), Class II (9.8 +/- 1.4 watts/kg), or Class III (10.5 +/- 1.8 watts/kg) mutations. There were no statistically significant differences in the lung function of patients with the different mutations. These results indicate a relationship between CF genotype and some measures of fitness, the mechanisms of which remain to be determined.
研究了患有囊性纤维化(CF)且至少携带一份DeltaF508突变拷贝的儿童的健康状况与基因型之间的关系。根据第二个CF突变对基因型进行分类。通过峰值有氧能力(在跑步机运动期间使用改良的布鲁斯方案)和无氧功率(在自行车测力计上使用温盖特测试)来测量健康状况。囊性纤维化跨膜调节蛋白(CFTR)突变类别与有氧能力、峰值无氧功率、体重指数、肺功能(一秒用力呼气量)以及通过施瓦克曼评分衡量的疾病严重程度在统计学上相关。导致CFTR产生缺陷(I类)或加工缺陷(II类)的突变患者的峰值有氧能力(分别为28.6±4.2毫升/千克/分钟和31.7±5.4毫升/千克/分钟)显著低于具有CFTR调节缺陷的突变患者(III类)(43.9±6.4毫升/千克/分钟)。诱导CFTR传导降低(IV类)或CFTR mRNA降低(V类)的突变受试者的峰值无氧功率(分别为11.4±1.7和11.6±1.5瓦/千克)显著高于I类(9.7±1.4瓦/千克)、II类(9.8±1.4瓦/千克)或III类(10.5±1.8瓦/千克)突变的儿童。不同突变患者的肺功能没有统计学上的显著差异。这些结果表明CF基因型与某些健康指标之间存在关系,其机制仍有待确定。